Revvity Stock Outlook: Is Wall Street Bullish or Bearish?

Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $10.3 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.

Shares of this specialty chemicals giant have notably underperformed the broader market over the past year. RVTY has declined 15% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 12.3%. In 2025, RVTY’s stock fell 16.6%, compared to the SPX’s 12.5% rise on a YTD basis.